Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Liabilities (2024 - 2025)

Carlsmed's Total Liabilities history spans 2 years, with the latest figure at $31.3 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 19.15% year-over-year to $31.3 million; the TTM value through Dec 2025 reached $31.3 million, up 19.15%, while the annual FY2025 figure was $31.3 million, 19.15% up from the prior year.
  • Total Liabilities reached $31.3 million in Q4 2025 per CARL's latest filing, up from $28.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $66.0 million in Q3 2024 to a low of $26.2 million in Q4 2024.